Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calves
Open Access
- 24 March 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
Abstract
Danofloxacin and enrofloxacin are fluoroquinolones (FQs) used to treat and control bovine respiratory disease (BRD) complex. While low toxicity, high bactericidal activity, and availability in single and multiple dosing regimens make them preferable, the increasing incidence of FQ-resistance in foodborne pathogens and effects on gut microbiota necessitate evaluating their pharmacokinetics (PKs). The objective of this study was to determine the exposure level of gut microbiota to subcutaneously administered FQs and compare their PKs between plasma and feces in healthy and Mannheimia haemolytica infected calves. A single dose of danofloxacin (8 mg/kg), low dose (7.5 mg/kg), or high dose (12.5 mg/kg) of enrofloxacin was administered to calves. Blood and feces were collected from calves under experimental conditions over 48 h, and FQ concentrations were measured using Ultra High-Pressure Liquid Chromatography. While moderate BRD signs were exhibited in most calves in the infected cohorts, the plasma PKs were similar between healthy and sick calves. However, the fecal danofloxacin concentration was lower in the BRD group (area under concentration–time curve [AUCinf], BRD median = 2627, healthy median = 2941 h*μg/mL, adj.P = 0.005). The dose normalized plasma and fecal danofloxacin concentrations were higher than those of enrofloxacin and its metabolite ciprofloxacin. Further, FQs had several fold higher overall concentrations in feces than in plasma in both groups. In conclusion, parenterally administered FQs expose gut microbiota to high concentrations of the antibiotics.Keywords
Funding Information
- USDA National Institute of Food and AgricultureAgriculture and Food Research (Agriculture and Food Research Initiative’s Competitive Grant 2017-68003-26499)
This publication has 43 references indexed in Scilit:
- Detection of clonal antigen receptor gene rearrangement in dogs with lymphoma by real-time polymerase chain reaction and melting curve analysisBMC Veterinary Research, 2014
- A simulation model for the prediction of tissue:plasma partition coefficients for drug residues in natural casingsThe Veterinary Journal, 2010
- Update on drugs prohibited from extralabel use in food animalsJournal of the American Veterinary Medical Association, 2009
- Concentrations of danofloxacin 18% solution in plasma, milk and tissues after subcutaneous injection in dairy cowsAnalytica Chimica Acta, 2009
- Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calvesJournal of Veterinary Pharmacology and Therapeutics, 2007
- Involvement of Breast Cancer Resistance Protein (ABCG2) in the Biliary Excretion Mechanism of FluoroquinolonesDrug Metabolism and Disposition, 2007
- Pharmacology of the fluoroquinolones: A perspective for the use in domestic animalsThe Veterinary Journal, 2006
- Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across speciesJournal of Veterinary Pharmacology and Therapeutics, 2004
- Pharmacokinetics of enrofloxacin in newborn and one‐week‐old calvesJournal of Veterinary Pharmacology and Therapeutics, 1997
- Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in ratsAntimicrobial Agents and Chemotherapy, 1995